| Literature DB >> 23190566 |
Britt-Marie Iresjö1, Kent Lundholm.
Abstract
BACKGROUND: Protein dynamics during non-steady state conditions as feeding are complex. Such studies usually demand combinations of methods to give conclusive information, particularly on myofibrillar proteins with slow turnover. Therefore, time course transcript analyses were evaluated as possible means to monitor changes in myofibrillar biosynthesis in skeletal muscles in conditions with clinical nutrition; i.e. long term exposure of nutrients.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23190566 PMCID: PMC3542095 DOI: 10.1186/1479-5876-10-238
Source DB: PubMed Journal: J Transl Med ISSN: 1479-5876 Impact factor: 5.531
Figure 1Electrophoretic separation of cytoskeletal proteins in L6 cells by stepwise purification. Cytoskeletal proteins were extracted using Calbiochems sub-cellular proteome extraction kit and separated by electrophoresis as described in Material and Methods. Lane 1–2 are autoradiograms of 35S-methionine labeled cells from low AA (lane 1) and high AA refed (lane 2) cells. Lane 3–4 are the same samples stained by Coomassie brilliant blue. Lane 5 is purified rabbit muscle actin (Sigma-Aldrich A-2522). Lane 6 is purified rabbit muscle myosin (Sigma-Aldrich M-1636). It has been demonstrated that L6 cells contain myosin [44].
Figure 2mRNA levels of Myosin heavy chain 2A, ACTA 1 and SLC38A2 in three different models with increased protein synthesis and translation initiation at amino acid provision. Rectus abdominus skeletal muscle tissue from surgical patients who received total parenteral nutrition compared to saline infusions for 12 hours; Mice “refed” with standard chow for 3 hours after 12 hours of starvation and L6 skeletal muscle cells cultured in presence of either low (0,28mM) or high (9 mM) total amino acid concentrations for 18 hours. Muscle MHC2A transcript levels were significantly decreased in parenterally fed patients (n=5) compared to saline infused control patients (n=5) (* p<0.05) while Mhc 2A /acta 1 transcrips were not different in mixed hind limb muscle tissue from starved/refed mice (Acta 1 p<0.10, MCH2A p<0.18, n=16) or cultured L6 cells (p<0.3). Slc38a2 (Snat2) levels were significantly decreased in L6 cells cultured in presence of high amino acid concentrations (p<0.01).
Figure 3mRNA levels of acta 1 and slc38a2 in confluent L6 cells refed low (0.28 mM) or high (9 mM) total amino amino acid concentrations compared to cells cultured for 24 hours in starvation medium (0,14 mM) as described in Materials and methods. Acta 1 was significantly increased in low and high AA refed cells at 60 min compared to 24 hours starved cells (p<0.01). Slc38a2 concentrations were decreased at 60 min (p<0.05, n=9).
Figure 4Transcript levels of acta 1and slc38a2 (Snat 2) in confluent L6 cells refed various groups of amino acids. L6 cells were cultured in the presence of low AA (0.28 mM) or high AA (9 mM) concentrations of all amino acids, or in the presence of high concentrations of various groups of amino acids (BCAA, aromatics, gln) in addition to background concentration of all amino acids in DMEM (0.14 mM) as described in Material and Methods. All cells were cultured in medium with decreased amounts of all amino acids (0.14 mM) for an initial period of 24 hours. Media were changed and cells were cultured in the presence of either low AA (0.28 mM), high AA (9 mM) or group amino acids for further 18 hours. (* p< 0.05 vs. refed low). RFBCAA = refed by BCAA (2.5 mM), RFArom = refed by aromatic amino acids (1mM), RFGlu = refed by Gln, Lys, Arg, Thr, His (5.3 mM).
Figure 5Time course changes in L-[U-C]-phenylalanine incorporation into proteins. Confluent L6 cells were cultured in medium containing very low amounts of amino acids (0,14 mM) for 24 hours, and then refed in low (0,28 mM) or high (9 mM) concentration of total AA concentrations, with constant specific radioactivity of phenylalanine (40 μCi/μmol phe). Cells were harvested by TCA-precipitation of proteins. (* p< 0.01 vs. low AA).
Altered transcript levels of amino acid transporters and muscle proteins in confluent L6 muscle cells refed high amino acid concentrations versus low amino acid concentration assessed in microarray experiments as described in Material and Methods
| A_44_P463878 | NM_181090 | Slc38a2 | Snat 2/ System A transporter | ||
| A_44_P393273 | | NM_053818 | Slc6a9 | Glyt1/ System Gly transporter | |
| A_44_P104652 | | NM_181090 | slc38a2 | Snat 2/ System A transport | |
| A_44_P510515 | | NM_017206 | Slc6a6 | Taut/ System BETA, taurine transport | |
| A_44_P410954 | | ENSRNOT00000011006 | Slc43a1_predicted | Lat 3/ System L-like transporter | |
| A_44_P994686 | | NM_012676 | Tnnt2 | Troponin T2, cardiac | |
| A_42_P786933 | | NM_012983 | Myo1d | Myosin 1D | |
| A_44_P489468 | ENSRNOT00000030661 | ENSRNOT00000030661 | Myosin heavy chain, smooth muscle isoform |
GO categories with significant enrichment of entities in L6 cells refed high amino acid concentrations
| 8636 | GO:0016126 | sterol biosynthetic process | 1.289 E-12 |
| 4323 | GO:0006695 | cholesterol biosynthetic process | 3.812 E-9 |
| 4322 | GO:0006694 | steroid biosynthetic process | 9.406 E-8 |
| 8635 | GO:0016125 | sterol metabolic process | 9.406 E-8 |
| 5578 | GO:0008610 | lipid biosynthetic process | 7.391 E-7 |
| 4260 | GO:0006629 | lipid metabolic process | 4.741 E-6 |
| 18769 | GO:0044255 | cellular lipid metabolic process | 3.867 E-6 |
| 3797 | GO:0006066 | alcohol metabolic process | 2.552 E-6 |
| 5262 | GO:0008203 | cholesterol metabolic process | 2.552 E-6 |
| 5261 | GO:0008202 | steroid metabolic process | 1.768 E-4 |
Based on entities selected by fold change ≥2.
Altered transcript levels (entities) in GO categories “steroid biosynthetic and metabolic processes” in confluent L6 muscle cells refed high amino acid concentrations
| A_44_P365580 | | NM_017136 | Sqle | Squalene epoxidase | |
| A_42_P814765 | | NM_001013071 | Tm7sf2 | Transmembrane 7 superfamily member 2 | |
| A_43_P16774 | NM_001006995 | Acat2 | Acetyl-Coenzyme A acetyltransferase 2 | ||
| A_42_P794613 | NM_031062 | Mvd | Mevalonate (diphospho) decarboxylase | ||
| A_44_P251944 | | NM_053539 | Idi1 | Isopentenyl-diphosphate delta isomerase | |
| A_43_P12843 | | NM_053539 | Idi1 | Isopentenyl-diphosphate delta isomerase ] | |
| A_44_P512136 | | NM_022389 | Dhcr7 | 7-dehydrocholesterol reductase | |
| A_44_P487240 | | NM_017268 | Hmgcs1 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | |
| A_44_P168285 | | NM_012941 | Cyp51 | Cytochrome P450, subfamily 51 | |
| A_43_P11890 | | NM_017268 | Hmgcs1 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | |
| A_44_P422696 | NM_031541 | Scarb1 | Scavenger receptor class B, member 1 | ||
| A_42_P796502 | | NM_017235 | Hsd17b7 | Hydroxysteroid (17-beta) dehydrogenase 7 | |
| A_44_P334218 | | NM_031049 | Lss | Lanosterol synthase (Lss) | |
| A_44_P379244 | | NM_031541 | Scarb1 | Scavenger receptor class B, member 1 | |
| A_44_P432965 | | NM_031840 | Fdps | Farensyl diphosphate synthase (Fdps) | |
| A_43_P22542 | | NM_001009399 | Nsdhl | NAD(P) dependent steroid dehydrogenase-like | |
| A_44_P347250 | | NM_001080148 | Dhcr24 | 24-dehydrocholesterol reductase | |
| A_43_P13043 | | NM_057137 | Ebp | Phenylalkylamine Ca2+ antagonist (emopamil) binding protein | |
| A_44_P143567 | | NM_031840 | Fdps | Farensyl diphosphate synthase | |
| A_44_P315661 | | NM_013134 | Hmgcr | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | |
| A_43_P13088 | | NM_080886 | Sc4mol | Sterol-C4-methyl oxidase-like | |
| A_43_P11729 | | NM_013134 | Hmgcr | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | |
| A_44_P237994 | | NM_053502 | Abcg1 | ATP-binding cassette, sub-family G (WHITE), member 1 | |
| A_44_P536613 | NM_001025415 | Ch25h | Cholesterol 25-hydroxylase |